Primaquine pharmacology in the context of CYP 2D6 pharmacogenomics: Current state of the art - ScienceDirect
Pharmacogenetic Testing and Opioids
Pharmacogenomics of Antidepressant Medications
How to Minimize Side Effects of Antidepressants | GeneSight
Intermediate metabolizer: increased side effects in psychoactive drug therapy. The key to cost-effectiveness of pretreatment CYP2D6 screening? | The Pharmacogenomics Journal
PPIS - Poor Metabolizers
Pharmacogenetic Study of the Response to Flecainide and Propafenone in Patients With Atrial Fibrillation | Revista Española de Cardiología
Disposition and Metabolic Fate of Atomoxetine Hydrochloride: The Role of CYP2D6 in Human Disposition and Metabolism | Drug Metabolism & Disposition
Pharmacogenetics for Safe Codeine Use in Sickle Cell Disease
ADHD Rx Pharmacokinetics & Pharmacodynamics — Pt. 4
CYP2C9 Polymorphism and Use of Oral Nonsteroidal Anti-Inflammatory Drugs